Compare · HDSN vs ZBH
HDSN vs ZBH
Side-by-side comparison of Hudson Technologies Inc. (HDSN) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- HDSN operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $16.88B, about 73.6x HDSN ($229.3M).
- Over the past year, HDSN is down 25.3% and ZBH is down 5.9% - ZBH leads by 19.4 points.
- ZBH has been more active in the news (15 items in the past 4 weeks vs 7 for HDSN).
- ZBH has more recent analyst coverage (25 ratings vs 11 for HDSN).
- Company
- Hudson Technologies Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $5.45+1.77%
- $87.32+0.01%
- Market cap
- $229.3M
- $16.88B
- 1M return
- +2.83%
- +4.71%
- 1Y return
- -25.34%
- -5.94%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 7
- 15
- Recent ratings
- 11
- 25
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest HDSN
- Hudson Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Hudson Technologies Receives Extension of Contract with the United States Defense Logistics Agency
- Amendment: Director Parrillo Richard bought $48,257 worth of shares (10,000 units at $4.83), increasing direct ownership by 5% to 195,746 units (SEC Form 4)
- Chief Financial Officer Bertaux Brian J. bought $9,740 worth of shares (2,000 units at $4.87) (SEC Form 4)
- Hudson Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Hudson Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Hudson Technologies Announces Open Market Share Purchases by the Board and Senior Management
- Director Mansy Loan Nguyen bought $24,814 worth of shares (5,000 units at $4.96), increasing direct ownership by 24% to 25,595 units (SEC Form 4)
- Director Parrillo Richard bought $24,814 worth of shares (5,000 units at $4.96), increasing direct ownership by 24% to 25,595 units (SEC Form 4)
- Director Bulgarino Nicole E bought $2,665 worth of shares (550 units at $4.84), increasing direct ownership by 5% to 11,048 units (SEC Form 4)
Latest ZBH
- SEC Form 4 filed by Officer Noor Jehanzeb
- Group President, Asia Pacific Yi Sang sold $413,216 worth of shares (5,000 units at $82.64), decreasing direct ownership by 16% to 27,251 units (SEC Form 4)
- Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Bernard Betsy J
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Shapiro Louis
- SEC Form 4 filed by Director Kurdikar Devdatt